Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia
Clinical trial NCT04275414 · COMPLETED
Trial details
- NCT number
- NCT04275414
- Sponsor
- Qilu Hospital of Shandong University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-15
- Primary completion
- 2020-04-05
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.